Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Schipper

Showing results (401-410 of 427) with videos related to

Pageof 43
Sort By:
ESMO Open|December 4, 2022
Complete genomic characterization in patients with cancer of unknown primary origin in routine diagnosticsL J Schipper, K G Samsom, P Snaebjornsson, et al.
NEJM Evidence|February 6, 2024
Meta-Analysis of Candidate Surrogate End Points in Advanced Prostate CancerLaila A Gharzai, Ralph Jiang, Elizabeth M Jaworski, et al.
Scientific Reports|September 28, 2020
Immune activation correlates with and predicts CXCR4 co-receptor tropism switch in HIV-1 infectionBridgette J Connell, Lucas E Hermans, Annemarie M J Wensing, et al.
Translational Oncology|April 23, 2022
Improved prediction of radiation pneumonitis by combining biological and radiobiological parameters using a data-driven Bayesian network analysisTonaye Hinton, David Karnak, Ming Tang, et al.
The Oncologist|April 6, 2021
Patient Burden with Current Surveillance Paradigm and Factors Associated with Interest in Altered Surveillance for Early Stage HPV-Related Oropharyngeal CancerLaila A Gharzai, Nicholas Burger, Pin Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 23, 2022
Biochemical Failure Is Not a Surrogate End Point for Overall Survival in Recurrent Prostate Cancer: Analysis of NRG Oncology/RTOG 9601William C Jackson, Ming Tang, Matthew J Schipper, et al.
Cancer Discovery|April 10, 2021
Werner Helicase Is a Synthetic-Lethal Vulnerability in Mismatch Repair-Deficient Colorectal Cancer Refractory to Targeted Therapies, Chemotherapy, and ImmunotherapyGabriele Picco, Chiara M Cattaneo, Esmée J van Vliet, et al.
JCO Precision Oncology|June 6, 2025
Cross-Comparison Individual Patient-Level Analysis of Three Gene Expression Signatures in Localized Prostate in Over 50,000 MenAngela Y Jia, Yilun Sun, Maitry Patel, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|November 25, 2023
Impact of genetic counseling strategy on diagnostic yield and workload for genome-sequencing-based tumor diagnosticsRoelof Koster, Luuk J Schipper, Noor A A Giesbertz, et al.
International Journal of Radiation Oncology, Biology, Physics|March 17, 2023
Initial Feasibility and Acute Toxicity Outcomes From a Phase 2 Trial of <sup>18</sup>F-Fluorodeoxyglucose Positron Emission Tomography Response-Based De-escalated Definitive Chemoradiotherapy for p16+ Oropharynx Cancer: A Planned Interim AnalysisSteven G Allen, Benjamin S Rosen, Madhava Aryal, et al.
Pageof 43

Showing results (401-410 of 427) with videos related to

Sort By:
Pageof 43
ESMO Open|December 4, 2022
Complete genomic characterization in patients with cancer of unknown primary origin in routine diagnosticsL J Schipper, K G Samsom, P Snaebjornsson, et al.
NEJM Evidence|February 6, 2024
Meta-Analysis of Candidate Surrogate End Points in Advanced Prostate CancerLaila A Gharzai, Ralph Jiang, Elizabeth M Jaworski, et al.
Scientific Reports|September 28, 2020
Immune activation correlates with and predicts CXCR4 co-receptor tropism switch in HIV-1 infectionBridgette J Connell, Lucas E Hermans, Annemarie M J Wensing, et al.
Translational Oncology|April 23, 2022
Improved prediction of radiation pneumonitis by combining biological and radiobiological parameters using a data-driven Bayesian network analysisTonaye Hinton, David Karnak, Ming Tang, et al.
The Oncologist|April 6, 2021
Patient Burden with Current Surveillance Paradigm and Factors Associated with Interest in Altered Surveillance for Early Stage HPV-Related Oropharyngeal CancerLaila A Gharzai, Nicholas Burger, Pin Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 23, 2022
Biochemical Failure Is Not a Surrogate End Point for Overall Survival in Recurrent Prostate Cancer: Analysis of NRG Oncology/RTOG 9601William C Jackson, Ming Tang, Matthew J Schipper, et al.
Cancer Discovery|April 10, 2021
Werner Helicase Is a Synthetic-Lethal Vulnerability in Mismatch Repair-Deficient Colorectal Cancer Refractory to Targeted Therapies, Chemotherapy, and ImmunotherapyGabriele Picco, Chiara M Cattaneo, Esmée J van Vliet, et al.
JCO Precision Oncology|June 6, 2025
Cross-Comparison Individual Patient-Level Analysis of Three Gene Expression Signatures in Localized Prostate in Over 50,000 MenAngela Y Jia, Yilun Sun, Maitry Patel, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|November 25, 2023
Impact of genetic counseling strategy on diagnostic yield and workload for genome-sequencing-based tumor diagnosticsRoelof Koster, Luuk J Schipper, Noor A A Giesbertz, et al.
International Journal of Radiation Oncology, Biology, Physics|March 17, 2023
Initial Feasibility and Acute Toxicity Outcomes From a Phase 2 Trial of <sup>18</sup>F-Fluorodeoxyglucose Positron Emission Tomography Response-Based De-escalated Definitive Chemoradiotherapy for p16+ Oropharynx Cancer: A Planned Interim AnalysisSteven G Allen, Benjamin S Rosen, Madhava Aryal, et al.
Pageof 43